N/A
Manufactured by Oystershell Consumer Health Inc
17 FDA adverse event reports analyzed
Last updated: 2026-04-15
PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Oystershell Consumer Health Inc. The most commonly reported adverse reactions for PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT include DRUG INEFFECTIVE, ABDOMINAL PAIN, APPLICATION SITE PAIN, CHEMICAL BURN, CRYING. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT.
Out of 6 classified reports for PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 17 FDA FAERS reports that mention PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, ABDOMINAL PAIN, APPLICATION SITE PAIN, CHEMICAL BURN, CRYING, DIARRHOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Oystershell Consumer Health Inc in connection with PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT. Always verify the specific product and NDC with your pharmacist.